Skip to content
Recall Observatory FDA recall evidence

Drug product

Oxcarbazepine Tablets, 150 mg, packaged in a) 10 x 10 count Unit-Dose Tablets in blisters packaged in a carton (NDC 0054-0097-20) and b) 100-count bottle (NDC 0054-0097-25), Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216

D-343-2014

March 18, 2013

Class III

Product summary

Firm
Boehringer Ingelheim Roxane Inc
Event
Event 66288
Status
Terminated
Classification
Class III
Quantity
8,550 cartons and bottles
Official record key
drug-enforcement:D-343-2014

Official wording

Reason: SubPotent Drug: The firm discovered out of specification results for assay and the extended investigation revealed the potential for lower weight tablets.

Code information: Lot #: a) 259666A, Exp. MAR 2014; b) 259666B, Exp. MAR 2014

Distribution pattern: Nationwide and Puerto Rico

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    SubPotent